236 related articles for article (PubMed ID: 16426060)
1. Physics-based scoring of protein-ligand complexes: enrichment of known inhibitors in large-scale virtual screening.
Huang N; Kalyanaraman C; Irwin JJ; Jacobson MP
J Chem Inf Model; 2006; 46(1):243-53. PubMed ID: 16426060
[TBL] [Abstract][Full Text] [Related]
2. Virtual ligand screening against Escherichia coli dihydrofolate reductase: improving docking enrichment using physics-based methods.
Bernacki K; Kalyanaraman C; Jacobson MP
J Biomol Screen; 2005 Oct; 10(7):675-81. PubMed ID: 16170049
[TBL] [Abstract][Full Text] [Related]
3. New scoring functions for virtual screening from molecular dynamics simulations with a quantum-refined force-field (QRFF-MD). Application to cyclin-dependent kinase 2.
Ferrara P; Curioni A; Vangrevelinghe E; Meyer T; Mordasini T; Andreoni W; Acklin P; Jacoby E
J Chem Inf Model; 2006; 46(1):254-63. PubMed ID: 16426061
[TBL] [Abstract][Full Text] [Related]
4. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
5. Protein flexibility in ligand docking and virtual screening to protein kinases.
Cavasotto CN; Abagyan RA
J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening against Mycobacterium tuberculosis dihydrofolate reductase: suggested workflow for compound prioritization using structure interaction fingerprints.
Kumar A; Siddiqi MI
J Mol Graph Model; 2008 Nov; 27(4):476-88. PubMed ID: 18829358
[TBL] [Abstract][Full Text] [Related]
7. Scoring ligand similarity in structure-based virtual screening.
Zavodszky MI; Rohatgi A; Van Voorst JR; Yan H; Kuhn LA
J Mol Recognit; 2009; 22(4):280-92. PubMed ID: 19235177
[TBL] [Abstract][Full Text] [Related]
8. Rescoring ligand docking poses.
Zhong S; Zhang Y; Xiu Z
Curr Opin Drug Discov Devel; 2010 May; 13(3):326-34. PubMed ID: 20443166
[TBL] [Abstract][Full Text] [Related]
9. Virtual screening against highly charged active sites: identifying substrates of alpha-beta barrel enzymes.
Kalyanaraman C; Bernacki K; Jacobson MP
Biochemistry; 2005 Feb; 44(6):2059-71. PubMed ID: 15697231
[TBL] [Abstract][Full Text] [Related]
10. Investigation of MM-PBSA rescoring of docking poses.
Thompson DC; Humblet C; Joseph-McCarthy D
J Chem Inf Model; 2008 May; 48(5):1081-91. PubMed ID: 18465849
[TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of scoring functions on a diverse test set.
Cheng T; Li X; Li Y; Liu Z; Wang R
J Chem Inf Model; 2009 Apr; 49(4):1079-93. PubMed ID: 19358517
[TBL] [Abstract][Full Text] [Related]
12. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
Radestock S; Weil T; Renner S
J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
[TBL] [Abstract][Full Text] [Related]
13. Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening.
Rastelli G; Degliesposti G; Del Rio A; Sgobba M
Chem Biol Drug Des; 2009 Mar; 73(3):283-6. PubMed ID: 19207463
[TBL] [Abstract][Full Text] [Related]
14. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA.
Rastelli G; Del Rio A; Degliesposti G; Sgobba M
J Comput Chem; 2010 Mar; 31(4):797-810. PubMed ID: 19569205
[TBL] [Abstract][Full Text] [Related]
15. Consensus scoring criteria for improving enrichment in virtual screening.
Yang JM; Chen YF; Shen TW; Kristal BS; Hsu DF
J Chem Inf Model; 2005; 45(4):1134-46. PubMed ID: 16045308
[TBL] [Abstract][Full Text] [Related]
16. Virtual screening against metalloenzymes for inhibitors and substrates.
Irwin JJ; Raushel FM; Shoichet BK
Biochemistry; 2005 Sep; 44(37):12316-28. PubMed ID: 16156645
[TBL] [Abstract][Full Text] [Related]
17. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
Schlosser J; Rarey M
J Chem Inf Model; 2009 Apr; 49(4):800-9. PubMed ID: 19354328
[TBL] [Abstract][Full Text] [Related]
18. Ligand-based virtual screening by novelty detection with self-organizing maps.
Hristozov D; Oprea TI; Gasteiger J
J Chem Inf Model; 2007; 47(6):2044-62. PubMed ID: 17854167
[TBL] [Abstract][Full Text] [Related]
19. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
Park H; Bhattarai BR; Ham SW; Cho H
Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
[TBL] [Abstract][Full Text] [Related]
20. Virtual screen for ligands of orphan G protein-coupled receptors.
Bock JR; Gough DA
J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
